CN Stock MarketDetailed Quotes

300937 Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical

Watchlist
  • 27.94
  • +1.39+5.24%
Market Closed Nov 6 15:00 CST
2.67BMarket Cap114.51P/E (TTM)

About Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Company

The company, formerly known as Sichuan Hezong Pharmaceutical Co., Ltd., was initially funded by Li Yanfei, Tian Wenwen, and Li Jin on April 28, 2007. The company's traditional business mainly covers pharmaceutical wholesale, pharmaceutical B2B e-commerce, and pharmaceutical offline retail. The company's growth business is mainly focused on the new industrial sector. The main products and services include Western medicine, proprietary Chinese medicines, Chinese herbal medicines, food and health food, medical devices and non-pharmaceuticals, and other categories, commercial B2B e-commerce systems, commercial wholesale ERP systems, commercial SCRM systems, retail chain ERP systems, integrated retail platform systems, clinic HIS systems, and value-added services for the development and application of intelligent coding, intelligent storage, intelligent pricing, intelligent product selection, joint drug use, pharmaceutical services, etc. Corporate honors: In 2022, the company was selected as a national e-commerce model enterprise by the Ministry of Commerce of the People's Republic of China; the company was elected as the Secretary General of the MAH Branch of the China Pharmaceutical Finance Association; the company was rated as “Sichuan New Business Format and New Model Innovative Enterprise” by the Sichuan Provincial Department of Commerce, the Sichuan Provincial Development and Reform Commission, and the Sichuan Provincial Market Supervision Administration; the company was rated as “Top 100 Private Pharmaceutical Enterprises in Chengdu” by the Chengdu Federation of Enterprises Federation of Industry and Commerce and the Pharmaceutical Business Branch of the Pharmaceutical Industry Chamber of Commerce of the All-China Federation of Industry and Commerce.

Company Profile

Short Name-A药易购
Symbol-A300937
Company NameSichuan Hezong Medicine Easy-To-Buy Pharmaceutical Co.,Ltd
Listing DateJan 27, 2021
Issue Price12.25
Shares Offered23.92M share(s)
FoundedApr 28, 2007
Legal Representativeyanfei li
General Managershunjun chen
Secretaryjinyang shen
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativejinyang shen
Legal CounselBeijing Deheng (Chengdu) Law Firm
Employees730
Phone028-83423435
Office Address13th Floor, No. 18, Youlian 1st Street, Jinniu District, Chengdu, Sichuan
Zip Code610081
Registered Address13th Floor, No. 18, Youlian 1st Street, Jinniu District, Chengdu, Sichuan
Fax028-83423435
Emailshenjinyang@hezongyy.com;hzxz@hezongyy.com
Business License510000000017188
BusinessWholesale of pharmaceuticals and pre-packaged food; sale of medical devices; (The operating projects and terms of the above projects are subject to the license). (The following items do not include pre-licensing projects; post-license projects operate with licenses or approval documents) Wholesale and retail of goods; business services; warehousing; handling services; road cargo transportation; import and export of goods or technology; data processing and storage services; value-added telecommunications services. (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • yanfei li
  • Chairman, Directors, Nomination Committee Members, Strategy and Development Committee Member, Audit Committee Members
  • 673.90K
  • yuewu zhou
  • Directors, Member of the Remuneration and Assessment Committee, Chairman of the Strategy and Development Committee
  • 240.00K
  • jinyang shen
  • Directors, Board Secretary, Securities Affairs Representative
  • 420.60K
  • yingping ai
  • Directors
  • 511.10K
  • shunjun chen
  • Directors, General Manager, Strategy and Development Committee Member
  • 1.03M
  • lei liu
  • Independent Directors, Nomination Committee Members, Strategy and Development Committee Member, Chairman of the Remuneration and Assessment Committee, Audit Committee Members
  • 50.00K
  • xiang luo
  • Independent Directors, Chairman of the Nomination Committee, Strategy and Development Committee Member
  • 50.00K
  • bofu deng
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • 50.00K
  • wenshu tian
  • Chairman of the Supervisory Board, Auditors
  • 269.00K
  • huasong chen
  • Auditors
  • 313.80K
  • deqiang zheng
  • Deputy General Manager, Chief Financial Officer
  • 663.80K
  • peipei zhao
  • Employee Supervisors
  • 212.20K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data